Federation Des Caisses Desjardins Du Quebec Alaunos Therapeutics, Inc. Transaction History

Federation Des Caisses Desjardins Du Quebec

$17.5 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Aug 14, 2024	SELL	$0.04 - $0.13 $9,783 - $31,797	-244,593 Reduced 58.16%	175,991 $12.5 Million
Q3 2023 Aug 14, 2024	SELL	$0.12 - $0.5 $183 - $765	-1,530 Reduced 0.36%	420,584 $55.5 Million
Q2 2023 Aug 14, 2024	BUY	$0.43 - $0.65 $6,645 - $10,045	15,455 Added 3.8%	422,114 $215 Million
Q1 2023 Aug 14, 2024	BUY	$0.46 - $0.81 $16,875 - $29,714	36,685 Added 9.92%	406,659 $256 Million
Q4 2022 Aug 14, 2024	SELL	$0.5 - $261.0 $782 - $408,465	-1,565 Reduced 0.42%	369,974 $240 Million
Q3 2022 Aug 14, 2024	BUY	$1.04 - $322.5 $65,535 - $20.3 Million	63,015 Added 20.42%	371,539 $639 Million
Q2 2022 Aug 14, 2024	BUY	$0.41 - $1.24 $27,470 - $83,080	67,000 Added 27.74%	308,524 $383 Million
Q1 2022 Aug 14, 2024	BUY	$0.62 - $1.17 $149,744 - $282,583	241,524 New	241,524 $157 Million
Q4 2021 Aug 30, 2024	BUY	$1.09 - $1.89 $31,937 - $55,377	29,300 Added 26.59%	139,501 $152 Million
Q3 2021 Aug 30, 2024	BUY	$1.44 - $2.73 $18,482 - $35,039	12,835 Added 13.18%	110,201 $201 Million
Q2 2021 Aug 30, 2024	BUY	$2.63 - $3.67 $256,072 - $357,333	97,366 New	97,366 $257 Million
Q1 2021 Aug 30, 2024	BUY	$2.82 - $5.6 $20,036 - $39,788	7,105 Added 8.06%	95,246 $343 Million
Q4 2020 Aug 30, 2024	BUY	$2.09 - $3.09 $3,772 - $5,577	1,805 Added 2.09%	88,141 $222 Million
Q2 2020 Aug 30, 2024	BUY	$2.2 - $3.71 $33,220 - $56,021	15,100 Added 21.2%	86,336 $283 Million
Q1 2020 Aug 30, 2024	BUY	$1.9 - $4.98 $1,871 - $4,905	985 Added 1.4%	71,236 $175 Million
Q4 2019 Aug 30, 2024	BUY	$3.95 - $5.35 $4,013 - $5,435	1,016 Added 1.47%	70,251 $332 Million
Q3 2019 Aug 30, 2024	BUY	$4.13 - $6.94 $34,051 - $57,220	8,245 Added 13.52%	69,235 $296 Million
Q2 2019 Aug 30, 2024	BUY	$3.98 - $6.2 $62,215 - $96,918	15,632 Added 34.46%	60,990 $356 Million
Q1 2019 Aug 30, 2024	BUY	$2.0 - $4.4 $52,436 - $115,359	26,218 Added 136.98%	45,358 $175 Million
Q4 2018 Aug 30, 2024	BUY	$1.61 - $3.62 $30,815 - $69,286	19,140 New	19,140 $35.8 Million
Q2 2018 Aug 30, 2024	BUY	$3.02 - $4.94 $9,165 - $14,992	3,035 Added 412.93%	3,770 $11.4 Million
Q1 2018 Aug 30, 2024	BUY	$3.46 - $5.14 $2,543 - $3,777	735 New	735 $2.88 Million

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account